About Innogene Kalbiotech
Established in Singapore in July 2003, Innogene Kalbiotech Ltd (IGK) develops and commercializes biopharmaceuticals and medical diagnostics, specializing in oncology, intensive care and therapeutic and preventive vaccines. It coordinates clinical trials and research activities, and manages the application and commercialization of patents worldwide. A wholly owned subsidiary of Jakarta-listed pharmaceutical company PT Kalbe Farma Tbk., IGK spearheads the innovation and globalization for Kalbe of research-based products.
Facts about Innogene Kalbiotech
Facts about Innogene Kalbiotech
- Focus : Manufacturer
- Industry : Biotechnology
